The National Institutes of Health has quietly closed a door that helped launch the careers of many physician-scientists. Starting in July 2027, its K-series career development awards will no longer pay for independent clinical trials. Young researchers can still observe and participate in trials run by their mentors. But they cannot lead one using K money. This shift, buried in a broader effort to streamline grants, has sent ripples through acad…